Innovative pharmaceutical concept stocks weaken in the short term, Nanxin Pharmaceutical falls more than 10%.

Concept stocks of innovative drugs weakened in the short term, with South New Pharmaceutical falling by more than 10%, Reyon Pharma falling by more than 8%, Shutaishen, Yuandong Biology, and Medici all declining.